Inflammatory Diseases Explained in Artistic Designs - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Inflammatory Diseases Explained in Artistic Designs


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 3

AbbVie has launched 'Perspectives – Art, Inflammation and Me', an initiative designed to add a different dimension to the current understanding of immune-mediated inflammatory diseases and their impact on patients and society. More than 100 artistic expressions from the initiative debuted at the 9th Congress of theEuropean Crohn's and Colitis Organization in Copenhagen, Denmark from Feb. 20-22.

The initiative involves more than 200 artists from 40 countries around the world. In addition to professional and independent artists, Perspectives included art studentsfrom more than 15 universities in France, Canada, Italy, and Spain through collaborations with the Polytechnic University of Valencia (Universitat Politecnica de Valencia).

The artistic expressions include, but are not limited to, sculptures, photographs, paintings, and installations. Perspectives will visit various art galleries and medical conferences throughout the world, with additional exhibition dates and locations to be announced.

Source: AbbVie

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here